Lion Asiapac Limited (SGX:BAZ)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions SGD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	31	25	24	28	37	31
Market Cap Growth	-	3.33%	-14.29%	-23.08%	19.74%	-9.52%
Enterprise Value	-5	-11	-21	-34	-28	-37
Last Close Price	0.38	0.31	0.30	0.27	0.34	0.29
PE Ratio	127.90	16.49	-	-	39.38	56.97
PS Ratio	0.87	0.60	0.78	0.92	1.81	1.71
PB Ratio	0.51	0.42	0.42	0.39	0.48	0.43
P/TBV Ratio	0.52	0.43	0.42	0.39	0.48	0.43
P/FCF Ratio	31.42	-	16.47	-	-	18.56
P/OCF Ratio	17.95	-	12.85	-	-	14.58
Debt / Equity Ratio	0.11	0.12	0.02	0.02	0.02	0.02
Debt / EBITDA Ratio	5.86	4.95	-	-	1.31	0.83
Debt / FCF Ratio	6.79	-	0.81	-	-	0.76
Asset Turnover	0.50	0.61	0.44	0.39	0.26	0.23
Inventory Turnover	2.68	4.38	4.63	4.65	3.17	2.74
Quick Ratio	5.45	4.59	9.95	15.80	24.11	23.75
Current Ratio	6.53	5.35	11.11	17.10	25.83	25.06
Return on Equity (ROE)	0.31%	2.45%	-4.61%	-2.09%	1.25%	0.73%
Return on Assets (ROA)	-0.27%	0.26%	-1.00%	-1.15%	0.09%	0.54%
Return on Capital (ROIC)	-0.29%	0.28%	-1.07%	-1.21%	0.09%	0.56%
Return on Capital Employed (ROCE)	-	0.50%	-	-	0.10%	0.90%
Earnings Yield	0.78%	6.07%	-12.35%	-5.50%	2.54%	1.75%
FCF Yield	3.18%	-21.30%	6.07%	-14.67%	-9.23%	5.39%
Dividend Yield	-	-	-	-	2.91%	-
Payout Ratio	-	-	-	-	-	75.05%
Total Shareholder Return	-	-	-	-	2.91%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.